LEXEO THERAPEUTICS INC
LXEO
Health Care
1
exclusion reason
1 theme
This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. But it is subject to change as our understanding of the facts evolves.
Lexeo Therapeutics is a clinical-stage genetic medicine company developing gene therapies for cardiovascular and central nervous system diseases. As a biotechnology firm conducting preclinical and clinical research, its operations inherently involve animal testing to evaluate the safety and efficacy of its therapeutic candidates. This testing is a standard, required component of the drug development pathway for regulatory approval.
The company’s pipeline includes programs for conditions like Friedreich’s ataxia and Alzheimer's disease, which are currently in various stages of investigation. The development of these gene therapies necessitates in vivo studies to assess biodistribution, dosing, and potential toxicity in animal models before proceeding to human trials. This commercial reliance on animal research places the company within the scope of the animal exploitation exclusion.
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.